TY - JOUR
T1 - Semi-continuous propagation of influenza A virus and its defective interfering particles
T2 - analyzing the dynamic competition to select candidates for antiviral therapy
AU - Pelz, Lars
AU - Rüdiger, Daniel
AU - Dogra, Tanya
AU - Alnaji, Fadi G
AU - Genzel, Yvonne
AU - Brooke, Christopher B
AU - Kupke, Sascha Y
AU - Reichl, Udo
N1 - Funding Information:
The work was supported by the Defense Advanced Research Projects Agency (https:// www.darpa.mil/program/intercept) INTERCEPT program under cooperative agreements W911NF-17-2-0012 and DARPA-16-35-INTERCEPT-FP-018.
Publisher Copyright:
© 2021 American Society for Microbiology. All rights reserved.
PY - 2021/12
Y1 - 2021/12
N2 - Defective interfering particles (DIPs) of influenza A virus (IAV) are naturally occurring mutants that have an internal deletion in one of their eight viral RNA (vRNA) segments, rendering them propagation-incompetent. Upon coinfection with infectious standard virus (STV), DIPs interfere with STV replication through competitive inhibition. Thus, DIPs are proposed as potent antivirals for treatment of the influenza disease. To select corresponding candidates, we studied de novo generation of DIPs and propagation competition between different defective interfering (DI) vRNAs in an STV coinfection scenario in cell culture. A small-scale two-stage cultivation system that allows long-term semi-continuous propagation of IAV and its DIPs was used. Strong periodic oscillations in virus titers were observed due to the dynamic interaction of DIPs and STVs. Using next-generation sequencing, we detected a predominant formation and accumulation of DI vRNAs on the polymerase-encoding segments. Short DI vRNAs accumulated to higher fractions than longer ones, indicating a replication advantage, yet an optimum fragment length was observed. Some DI vRNAs showed breaking points in a specific part of their bundling signal (belonging to the packaging signal), suggesting its dispensability for DI vRNA propagation. Over a total cultivation time of 21 days, several individual DI vRNAs accumulated to high fractions, while others decreased. Using reverse genetics for IAV, purely clonal DIPs derived from highly replicating DI vRNAs were generated. We confirm that these DIPs exhibit a superior in vitro interfering efficacy compared to DIPs derived from lowly accumulated DI vRNAs and suggest promising candidates for efficacious antiviral treatment.
AB - Defective interfering particles (DIPs) of influenza A virus (IAV) are naturally occurring mutants that have an internal deletion in one of their eight viral RNA (vRNA) segments, rendering them propagation-incompetent. Upon coinfection with infectious standard virus (STV), DIPs interfere with STV replication through competitive inhibition. Thus, DIPs are proposed as potent antivirals for treatment of the influenza disease. To select corresponding candidates, we studied de novo generation of DIPs and propagation competition between different defective interfering (DI) vRNAs in an STV coinfection scenario in cell culture. A small-scale two-stage cultivation system that allows long-term semi-continuous propagation of IAV and its DIPs was used. Strong periodic oscillations in virus titers were observed due to the dynamic interaction of DIPs and STVs. Using next-generation sequencing, we detected a predominant formation and accumulation of DI vRNAs on the polymerase-encoding segments. Short DI vRNAs accumulated to higher fractions than longer ones, indicating a replication advantage, yet an optimum fragment length was observed. Some DI vRNAs showed breaking points in a specific part of their bundling signal (belonging to the packaging signal), suggesting its dispensability for DI vRNA propagation. Over a total cultivation time of 21 days, several individual DI vRNAs accumulated to high fractions, while others decreased. Using reverse genetics for IAV, purely clonal DIPs derived from highly replicating DI vRNAs were generated. We confirm that these DIPs exhibit a superior in vitro interfering efficacy compared to DIPs derived from lowly accumulated DI vRNAs and suggest promising candidates for efficacious antiviral treatment.
KW - Antiviral
KW - Continuous virus production
KW - Defective interfering particles
KW - Influenza A virus
KW - Next-generation sequencing
UR - http://www.scopus.com/inward/record.url?scp=85120037844&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85120037844&partnerID=8YFLogxK
U2 - 10.1128/JVI.01174-21
DO - 10.1128/JVI.01174-21
M3 - Article
C2 - 34550771
SN - 0022-538X
VL - 95
SP - JVI0117421
JO - Journal of virology
JF - Journal of virology
IS - 24
M1 - e01174-21
ER -